Kalaris Therapeutics, Inc. KLRS
1.87 USD -0.43 (-18.70%)
At closeNov 10, 2026, 4:00 PM EST
1.95 +0.08 +4.28%
After hours · Nov 10, 4:00 PM ET
1.80 Day range 2.38
1.78 52-week range 11.88
- YTD
- -77.84%
- 1 year
- -61.04%
- Market cap
- 44.52M
- EPS (ttm)
- -1.84
- YTD return
- -77.84%
- 1-year return
- -61.04%
- Volume
- 81.44K
- Avg volume
- 70.03K
- Open
- 2.20
- Previous close
- 2.30
- Day's range
- 1.80 – 2.38
- 52-week range
- 1.78 – 11.88
No chart data for this range yet.
Financials — quick view
KLRS Revenue — quarterly 0
KLRS Net income — quarterly -11.52M
KLRS EPS — quarterly -0.48
News
Kalaris Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate 
Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update 
Alpha Buying: 3 Beaten-Down Biotech Stocks Backed by a Specialist Investor 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
Kalaris Therapeutics Inc. (NASDAQ:KLRS) Stock Has Average Price Target of $18.75 
Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference 
Kalaris Therapeutics Q2 EPS $(0.48) Beats $(0.49) Estimate 
Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates 
Kalaris Therapeutics (NASDAQ:KLRS) Shares Up 15.4% – Here’s What Happened
Your note
Sign in to keep a note on KLRS — it syncs with the Stock Master app.